# A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer

> **NCT00531245** · PHASE1,PHASE2 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 77 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** TS-1, oxaliplatin

## Key facts

- **NCT ID:** NCT00531245
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2008-06
- **Final completion:** 2009-03
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2009-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00531245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00531245, "A Phase I/II Trial of TS-1 and Oxaliplatin in Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00531245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*